{"id":"https://openalex.org/W2052296210","doi":"https://doi.org/10.1002/pds.2630040610","title":"Aspirin and paracetamol: Changing pattern of use in Spain","display_name":"Aspirin and paracetamol: Changing pattern of use in Spain","alternate_titles":[],"publication_year":1995,"publication_date":"1995-11-01","ids":{"openalex":"https://openalex.org/W2052296210","doi":"https://doi.org/10.1002/pds.2630040610","mag":"2052296210"},"language":"en","primary_location":{"id":"doi:10.1002/pds.2630040610","doi":"https://doi.org/10.1002/pds.2630040610","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2630040610","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052296210"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067280353","display_name":"Alfonso Carvajal Garc\u00eda\u2010Pando","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfonso Carvajal Garc\u00eda\u2010Pando","raw_affiliation_strings":["Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]},{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Luis Martin Arias","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Martin Arias","raw_affiliation_strings":["Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]},{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082559146","display_name":"Isaac Mart\u00edn de Diego","orcid":"https://orcid.org/0000-0001-5197-2932","observed_orcids":["https://orcid.org/0000-0001-5197-2932"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isaac Mart\u00edn de Diego","raw_affiliation_strings":["Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]},{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112347388","display_name":"Alfonso Velasco Mart\u00edn","orcid":"https://orcid.org/0009-0005-4306-3399","observed_orcids":["https://orcid.org/0009-0005-4306-3399"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfonso Velasco Martin","raw_affiliation_strings":["Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Leo\u0301n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]},{"raw_affiliation_string":"Centro Regional de Farmacovigilancia de Castilla y Le\u00f3n, Faculty of Medicine, 47005 Valladolid, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"6","first_page":"381","last_page":"382"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.5005000233650208,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.5005000233650208,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.23109999299049377,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":1.0},{"id":"https://openalex.org/keywords/paracetamol","display_name":"paracetamol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/analgesic-use","display_name":"analgesic use","score":0.7239999771118164},{"id":"https://openalex.org/keywords/drug-use-trends","display_name":"drug use trends","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.5401749610900879},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4105464816093445},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.1816781461238861}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/pds.2630040610","doi":"https://doi.org/10.1002/pds.2630040610","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.2630040610","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1976252470","https://openalex.org/W1986003353","https://openalex.org/W4231592681"],"related_works":["https://openalex.org/W1973557619","https://openalex.org/W4254104371","https://openalex.org/W2079085841","https://openalex.org/W2481135978","https://openalex.org/W1995227415","https://openalex.org/W4301624301","https://openalex.org/W1866437770","https://openalex.org/W2263960381"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2052296210","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
